Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

7792 ARTÍCULOS , VIENDO DEL 6406 AL 6420

Very Late-Onset Neurodegeneration with Brain Iron Accumulation Associated with Mild Chorea: A Clinicopathological Case

Sipilä JOT, Hietaharju A, Saukkonen AM, Kytövuori L, Balk L, Kaasinen V, Rauramaa T.

Mov Disord Clin Pract. 2025 Jun;12(6):835-841. doi: 10.1002/mdc3.70032. Epub 2025 Mar 13.

Beyond the Globus Pallidus: A Systematic Review of Deep Brain Stimulation of Extrapallidal Targets for Pediatric Movement Disorders

Sulistyo A, Vogt LM, Algethami H, Cunningham J, Breitbart S, LeBlanc-Millar A, Fasano A, Ibrahim GM, Gorodetsky C.

Neuromodulation. 2025 Dec 4:S1094-7159(25)01104-3. doi: 10.1016/j.neurom.2025.10.056. Online ahead of print.

A phase I, open-label study of intravenous human dental pulp stem cells (NestaCell®) at two dose levels in patients with Huntington's disease

Fernandes JMS, Pagani E, Wenceslau CV, Ynoue LH, Ferrara L, Kerkis I.

Stem Cell Res Ther. 2025 Nov 4;16(1):611. doi: 10.1186/s13287-025-04703-w.

Redox chemical delivery system: an innovative strategy for the treatment of neurodegenerative diseases

Prajapati JL, Dhurandhar Y, Singh AP, Gupta DK, Baghel VS, Kushwaha U, Namdeo KP.

Expert Opin Drug Deliv. 2025 Jun;22(6):805-822. doi: 10.1080/17425247.2025.2489558. Epub 2025 Apr 10.

Feasibility and effects of cognitive training on cognition and psychosocial function in Huntington's disease: a randomised pilot trial

Huynh K, Jamadar SD, Lampit A, Siddiqui MN, Stout JC, Georgiou-Karistianis N.

J Neurol. 2025 Jan 23;272(2):159. doi: 10.1007/s00415-024-12855-7.

Interplay between exercise and neuregulin in providing neuroprotection

Sharma J, Thakur A, Rain M, Khosla R, Maity K, Mathur GR, Anand A.

Behav Brain Res. 2025 Sep 13;493:115710. doi: 10.1016/j.bbr.2025.115710. Epub 2025 Jun 24.

Pearls & Oy-sters: ADCY5-Related Dyskinesia: From a Longstanding Misdiagnosis of Drug-Resistant Epilepsy

Moreno-Estébanez A, Sánchez-Horvath M, Marinas A, Catalli C, Fernandez-Valle T, de Ceballos P, Lagüela Alonso A, Garamendi Ruiz I.

Neurology. 2025 May 27;104(10):e213661. doi: 10.1212/WNL.0000000000213661. Epub 2025 Apr 29.

Chorea in Hereditary Leukodystrophies - Overview of Two Cases

Milovanović A, Ječmenica-Lukić M, Mazalica N, Radišić V, Đorđević-Milošević M, Marjanović A, Branković M, Marković V, Kresojević N, Kostić V, Dragašević-Mišković N.

Tremor Other Hyperkinet Mov (N Y). 2025 Dec 11;15:62. doi: 10.5334/tohm.1103. eCollection 2025.

Author Correction: Huntington's disease cellular phenotypes are rescued non-cell autonomously by healthy cells in mosaic telencephalic organoids

Galimberti M, Nucera MR, Bocchi VD, Conforti P, Vezzoli E, Cereda M, Maffezzini C, Iennaco R, Scolz A, Falqui A, Cordiglieri C, Cremona M, Espuny-Camacho I, Faedo A, Felsenfeld DP, Vogt TF, Ranzani V, Zuccato C, Besusso D, Cattaneo E.

Nat Commun. 2025 May 21;16(1):4723. doi: 10.1038/s41467-025-60108-6.

Presentation Modes, Anticipation, and Penetrance: A Case Series of Huntington's Disease

Sumaiya T, Sultana R, Mridul MH.

Cureus. 2025 Oct 8;17(10):e94101. doi: 10.7759/cureus.94101. eCollection 2025 Oct.

Factors affecting the physical stability of peptide self-assembly in neurodegenerative disorders

Saikia J, Sarkar M, Ramakrishnan V.

Neuropeptides. 2025 Jun;111:102517. doi: 10.1016/j.npep.2025.102517. Epub 2025 Mar 13.

Application of Natural Products in Neurodegenerative Diseases by Intranasal Administration: A Review

Jin Y, Ma X, Liu S, Zong S, Cheng Y, Zhang H, Wang C, Li Y.

Pharmaceutics. 2025 May 20;17(5):675. doi: 10.3390/pharmaceutics17050675.

AMPA receptor diffusional trapping machinery as an early therapeutic target in neurodegenerative and neuropsychiatric disorders

Choquet D, Opazo P, Zhang H.

Transl Neurodegener. 2025 Feb 11;14(1):8. doi: 10.1186/s40035-025-00470-z.

From Yeast to Therapeutics: Modeling Neurodegenerative Diseases in Saccharomyces cerevisiae

Ferreira-Junior JR, de Lima Camandona V, Barros MH.

Yeast. 2025 Dec;42(12):283-302. doi: 10.1002/yea.70008. Epub 2025 Nov 24.

Sirtuins as Therapeutic Targets for Treating Cancer, Metabolic Diseases, and Neurodegenerative Diseases

Akantibila M, Carabetta VJ.

Pharmaceuticals (Basel). 2025 Nov 13;18(11):1723. doi: 10.3390/ph18111723.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias